日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / From the Press

Politics of vaccine development is to dominate UK vaccine summit

By Stephen Ndegwa | CGTN | Updated: 2020-04-27 16:00
Share
Share - WeChat
A double-decker red bus passes by the Bank of England in London, Britain, March 6, 2019. /Xinhua

On April 24, the United Kingdom announced that it will host the Global Vaccine Summit on June 4, 2020, virtually. The communique released by the UK government says the summit is an important milestone in supporting the Global Alliance for Vaccines and Immunization (GAVI) to "strengthen health systems around the world and help to tackle coronavirus in some of the world's poorest countries."

The summit will also be crucial in securing support for GAVI's five-year strategy, which aims at immunizing 300 million children, and saving 8 million lives by 2025. Of course, these figures will now be reviewed in light of the emergence of the deadly coronavirus.

The announcement for the UK summit was apt, having been made on the eve of World Malaria Day (WMD), which was celebrated on April 25. The theme of the international day was "Malaria: Status Update on Children."

As the United Nations Children's Fund (UNICEF) notes in its WMD bulletin, "the overlap of COVID-19 and malaria could have potentially highly lethal consequences for children under-five if we don't respond soon to ensure continuity of services."

UNICEF notes that the major challenge of managing malaria in a highly charged COVID-19 environment is to ensure continuity of care-seeking behavior as people with fevers might push back on seeking treatment due to fear of contracting or spreading COVID-19.

The World Health Organization (WHO) is currently leading malaria vaccine trials in three African countries – Ghana, Malawi and Kenya – which it says were chosen in a competitive process.

Recently, the WHO mobilized and gained consensus of the international community in accelerating research sharing on a coronavirus vaccine, as well as the sharing of research, treatment, and medicines on the pandemic.

Countries that are currently engaged in COVID-19 vaccine initiatives include China, Germany, the UK, and the U.S., with all at advanced stages of clinical trials using human volunteers.

The Bill and Melinda Gates Foundation, a major vaccine financier, and the Coalition for Epidemic Preparedness Innovations are collaborating in what they tout as the fastest vaccine search in history.

Speaking to BBC last week, the foundation's co-chairman Bill Gates said while it normally takes five or six years to develop a vaccine, he foresees a COVID-19 vaccine in 18 months. Indeed, current efforts are both lofty ambitions and desperate efforts.

According to the Centers for Disease Control and Prevention, there are six main stages in the development of a vaccine, including exploratory, pre-clinical, clinical development, regulatory review and approval, manufacturing and quality control.

Vaccine development, as a rigorous multi-sectoral exercise, requires meticulous work from a variety of professionals and other stakeholders. Besides that, there are fears that the current race for a vaccine will disadvantage poor countries, as the rich ones might buy in massive volumes for both current use and stock ups.

This time round poor countries are expressing a need for more transparency and accountability on vaccine testing. Previously, vaccine makers and their financiers have been accused of using citizens of developing countries as guinea pigs, by exploiting their prevalent poverty and weak governance systems.

In Africa, the polio vaccine, whose development and production has been supported by the Gates Foundation, has been called out a few times by the Catholic Church for allegedly being laced with female contraceptives, among having other adverse health outcomes. The planned tests on the efficacy of the COVID-19 vaccine has, yet again, touched a raw nerve.

In Kenya, President Uhuru Kenyatta on Saturday urged the country's citizens to ignore controversial views by BBC medical correspondent Fergus Walsh, who in a radio interview last week stated, "we are desperate for this vaccine to work but the team in Oxford… if they don't get early quick results from the UK they are considering a trial in Kenya where the epidemic of the coronavirus will be on the rise."

We expect to hear similar politics as the advanced countries compete on who will be first past the line in the race of the vaccine against COVID-19.

During the vaccine summit, poor countries are expected to lobby for the signing of a global agreement that ensures transparency in the vaccine development protocols, and a fair level of equity in the allocation of the vaccine.

Ultimately, we need to heed the words of former U.S. Secretary of State Madeleine Albright, who on Friday in an interview with ABC Australia observed, "we are blaming the Chinese for what happened. But the bottom line is we depend on the masks they make. If they are the ones that invent the vaccines, will we say no?"

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 谍影在线观看电视剧完整版 | www.qubook.| 国产亚洲精品久久久久久无码网站 | 亚洲天堂视频在线观看免费 | 九九色网站 | 欧美精品色 | 亚洲va国产va | 亚洲在线免费视频 | 国产成人综合一区精品 | 欧美成人二区 | 毛片1级| 一区二区日韩精品 | 精品一区二区三区四区 | 天堂中文资源网 | 最新亚洲国产有精品 | av国产片| 色屁屁www影院入口免费观看 | 久久久一区二区三区视频 | 99久久99久久 | 国产视频网 | 欧美一级精品片在线看 | a久久 | 亚洲综合国产 | 久久久精彩视频 | 国产免费高清无需播放器 | 1级片在线观看 | 天天做夜夜操 | 一级欧美在线的视频 | 亚洲二区视频 | 日日摸天天碰中文字幕 | 小明永久成人一区二区 | 天天躁日日躁狠狠很躁 | 精品亚洲一区二区三区四区五区 | 国产激情在线观看 | 99视频在线精品 | 最新伦理片 | 欧美精品一区二区三区在线播放 | 国产综合婷婷 | 国产成人免费永久播放视频平台 | 欧美亚洲理伦电影毛片在线播放 | 亚洲国产精品一区二区三区久久 |